Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Data: The crypto market is broadly down, with the Layer2 sector leading the decline by nearly 8%. BTC falls below $88,000.

Data: The crypto market is broadly down, with the Layer2 sector leading the decline by nearly 8%. BTC falls below $88,000.

ChaincatcherChaincatcher2025/12/01 06:32
Show original

ChainCatcher News, according to SoSoValue data, the overall crypto market is experiencing a general decline, with 24-hour drops ranging from approximately 3% to 8%. The Layer2 sector is leading the decline with a 7.72% drop. Within the sector, Starknet (STRK) fell by 13.13%, and zkSync (ZK) dropped by 10.99%. In addition, Bitcoin (BTC) fell by 3.91%, dropping below $88,000; Ethereum (ETH) fell by 5.17%, dropping below $2,900.

In other sectors, the CeFi sector fell by 3.90% over 24 hours. Within the sector, HashKey Platform Token (HSK) remained relatively resilient, rising by 1.35%. In terms of news, HSK has passed the Hong Kong Stock Exchange hearing and plans to go public in Hong Kong. The PayFi sector dropped by 4.85%, but Monero (XMR) rose by 3.55%. The Layer1 sector fell by 5.31%, with Zcash (ZEC) dropping by 17.38%. The Meme sector dropped by 5.44%, while MemeCore (M) bucked the trend and rose by 7.15%. The DeFi sector fell by 6.40%, with MYX Finance (MYX) surging by 8.21% during trading. The AI sector fell by 6.84%, but SoSoValue (SOSO) rose by 8.43% within the sector.

The crypto sector indices reflecting historical sector performance show that the ssiAI, ssiDePIN, and ssiGameFi indices fell by 8.23%, 8.22%, and 7.67% respectively.

News Image 0
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

JPMorgan maintains "Neutral" rating on Johnson & Johnson (JNJ.US): Strong data from two anti-cancer drugs, but valuation premium limits upside potential

Johnson & Johnson’s new prostate cancer drug and head and neck cancer drug Ervantumab both released positive data at ESMO. JPMorgan stated that the pipeline shows differentiated potential but valuations are relatively high, maintaining a Neutral rating.

智通财经•2026/10/26 06:37

AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch

Two U.S. leveraged ETFs linked to SK Hynix (SKHY.US)—the Tradr 2X Long SK Hynix Daily ETF and the Tradr 2X Short SK Hynix Daily ETF—will be liquidated around November 12, approximately three months after their listing on July 28.

智通财经•2026/10/26 06:32
AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.